Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Editas Medicine, Inc. (EDIT) had Weighted-Average Shares Outstanding (Diluted) of 75.97M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$78.12M |
|
$-153.22M |
|
-- |
|
$78.12M |
|
$247.30M |
|
$-169.18M |
|
$15.96M |
|
$-153.22M |
|
$-153.22M |
|
$-153.22M |
|
$-153.22M |
|
$-153.22M |
|
$-153.22M |
|
$-169.18M |
|
$-167.94M |
|
75.97M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
75.97M |
$-2.02 |
|
$-2.02 |
|
| Balance Sheet Financials | |
$340.83M |
|
$12.03M |
|
$158.32M |
|
$499.15M |
|
$63.22M |
|
-- |
|
$86.84M |
|
$150.06M |
|
$349.10M |
|
$349.10M |
|
$349.10M |
|
81.77M |
|
| Cash Flow Statement Financials | |
$-132.18M |
|
$-3.73M |
|
$118.04M |
|
$145.40M |
|
$127.53M |
|
$-17.87M |
|
$19.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-216.56% |
|
-216.56% |
|
-214.97% |
|
-196.13% |
|
-196.13% |
|
$-136.90M |
|
-- |
|
-- |
|
-- |
|
0.16 |
|
-- |
|
7.67 |
|
47.59 |
|
-43.89% |
|
-43.89% |
|
-30.70% |
|
-43.89% |
|
$4.27 |
|
$-1.80 |
|
$-1.74 |
|